Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12285472
Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
granted -
US 12286407
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 12281021
System and method for making boron oxide nanoparticles
granted -
US 12275966
Genetically engineered cells
granted -
US 12275964
Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
granted -
US 12269805
Inhibitors of platelet function and methods for use of the same
granted -
US 12268777
Compositions and methods for treating eosinophilic disorders
granted -
US 12268678
Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
granted -
US 12268683
Compounds and methods for synergistic activation of M channels
granted -
US 12264336
Platform for generating safe cell therapeutics
granted -
US 12257325
Chelating platform for delivery of radionuclides
granted -
US 12258575
RNA-guided nucleic acid modifying enzymes and methods of use thereof
granted -
US 12257326
TCO conjugates and methods for delivery of therapeutic agents
granted -
US 12257266
Stem cell-derived exosomes for the treatment of corneal scarring
granted -
US 12258612
Random heteropolymers preserve protein function in foreign environments
granted -
US 12257235
Methods and materials for using ruminococcus gnavus or clostridium sporogenes to treat gastrointestinal disorders
granted -
US 12252746
Anti-CD46 antibodies and methods of use
granted -
US 12251372
Antileishmanial compounds, compositions and use thereof
granted -
US 12251379
Methods of inhibiting formation of alpha synuclein aggregates
granted -
US 12252515
Compositions and methods for inhibiting Wnt signaling
granted -
US 12246086
Applications and imaging of shear-thinning biomaterial
granted -
US 12246096
Self-assembled microcapsules with stimuli-responsive organic ligands
granted -
US 12239694
Methods and compositions for improved cognition
granted -
US 12241902
Probes for detection of copper
granted